Ortin Laboratories Ltd.

19.48 +0.17 ▲0.9%

23 April 2024, 04:01:00 PM
Volume: 1,416

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ortinlabsindia.com
Market Cap 15.84 Cr.
Enterprise Value(EV) 21.52 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -5.01 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 41.03 Trailing Twelve Months Ending 2023-12
Book Value / Share 8.57 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.27 Calculated using Price: 19.48
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.81 Cr. 8,131,392 Shares
FaceValue 10
About Ortin Laboratories Ltd.
Ortin Laboratories established in the year 1986 was a private limited company with a nominal capital of Rs 1 lakh to offer quality drugs and medicines to the suffering mankind. Later, in the year 1994, this private limited company converted as a public limited company with 5,060 shareholders which received good subscription from the public. These proceeds were utilised for constructing a factory in a spacious area of 25000 sq feet with all ultra-modern infrastructure as per the WHO GMP Standards to manufacture the complete range of Pharmaceutical Formulations of Tablets, Capsules, Syrups, Dry Powders & Ointments. Due to its concern for quality, the company stands as a leading and predominant pharmaceutical manufacturer of drugs and medicines of the country with turnover running in crores of rupees.

Ortin Laboratories Ltd. Delivery

Delivered Qty
Traded Qty

Ortin Laboratories Ltd. Performance

1 Day
+0.88%
1 Week
+1.99%
1 Month
+9.25%
3 Month
-7.63%
6 Month
-4.51%
1 Year
-1.02%
2 Year
-30.68%
5 Year
+35.28%
10 Year
+37.57%

Ortin Laboratories Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 4.04 3.65 2.16 2.86 5.21 -2.31 5.38 -3.57 -0.86
Return on Capital Employed (%) 11.55 11.01 9.58 10.14 11.76 8.93 3.27 1.56 1.66
Return on Assets (%) 1.28 1.25 0.79 1 1.43 -0.51 1.37 -1.9 -0.45

Ortin Laboratories Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 22 23 23 24 25 24 11 11 11 10
Non Curr. Liab. 8 16 8 8 8 9 2 2 3 3
Curr. Liab. 37 27 31 42 72 84 8 8 7 6
Minority Int.
Equity & Liab. 68 66 62 74 105 117 21 21 21 18
Non Curr. Assets 24 35 23 21 23 24 15 15 15 15
Curr. Assets 44 31 38 52 82 92 6 6 7 4
Misc. Exp. not W/O
Total Assets 68 66 62 74 105 117 21 21 21 18

Ortin Laboratories Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 60 63 67 80 168 197 8 8 6 3
Other Income 0 1 0 0 1 0 0 0 0 0
Total Income 61 64 67 80 168 198 8 8 6 3
Total Expenditure -54 -57 -61 -74 -162 -192 -7 -8 -6 -7
PBIDT 7 6 6 6 7 6 1 1 1 -3
Interest -4 -3 -3 -3 -3 -3 -1 -1 0 -1
Depreciation -2 -2 -2 -2 -2 -2 0 0 0 0
Taxation 0 -1 -1 -1 -1 1 0 0 0
Exceptional Items 0
PAT 1 1 1 1 1 -1 1 0 0 -4
Adjusted EPS 1 0 0 0 1 0 1 0 0 -5

Ortin Laboratories Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. -2 -1 1 2 2 7 3 18 2 0
Cash Fr. Inv. 0 0 -1 -1 -1 -3 -3 0 0 0
Cash Fr. Finan. 1 2 0 -1 0 -3 -1 -10 0 1
Net Change -1 1 0 0 1 0 -1 8 2 1
Cash & Cash Eqvt 1 2 2 -14 -13 -13 -14 -5 -4 -3

Ortin Laboratories Ltd. Shareholding Pattern

9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 15.68 15.68 15.68 15.68 21.51 7.36 7.37 7.36 1.23
Public 84.32 84.32 84.32 84.32 78.49 92.64 92.63 92.64 98.77
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Ortin Laboratories Ltd. Announcements

Sat, 20 Apr 2024
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.

Sr. No. Particulars Details
1 Name of Company Ortin Laboratories Ltd
2 CIN NO. L24110TG1986PLC006885
3 Report filed for FY 2023-2024
Details of the Current block (all figures in Rs crore):
4 2 - year block period (Specify financial years)* FY 2024-25 FY 2023-24
5 Incremental borrowing done in FY (T)(a) 0.00
6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00
7 Actual borrowing done through debt securities in FY (T)(c) 0.00
8 Shortfall in the borrowing through debt securities if any for FY (T - 1) carried forward to FY (T) (d) 0
8Quantum of (d) which has been met from (c)(e)* 0
9 Shortfall if any in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative write nil}* 0


Details of penalty to be paid if any in respect to previous block (all figures in Rs crore):
2 - year Block period (Specify financial years)FY 2023-24 2022-23
Amount of fine to be paid for the block if applicable Fine = 0.2% of {(d) - (e)}#0.00



Name of the Company Secretary :-Divya Purswani
Designation :-Company Secretary and Compliance Officer
Name of the Chief Financial Officer :- Srinivasa Kumar Sanka
Designation : -CFO

Date: 20/04/2024

Wed, 17 Apr 2024
Disclosure Under Regulation 40(9) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 For The FY Ending 31.03.2024
Disclosure under regulation 40(9) of SEBI (Listing Obligation and Disclosure Requirements ) Regulations 2015 for the FY ending 31.03.2024
Wed, 17 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Compliance Certificate under Reg.74 (5) of SEBI (DP) Regulations 2018 for the Quarter and year ended 31.03.2024

Ortin Laboratories Ltd. Technical Scans

Mon, 22 Apr 2024
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
High Increase in 1 Month High Increase in 1 Month
William %R Trending Down William %R Trending Down
ROC Trending Down ROC Trending Down

Ortin Laboratories Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 356,001.33 1,484.65 -3.6%
Cipla Ltd. 108,812.62 1,346.70 -0.6%
Divi's Laboratories Ltd. 100,075.02 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. 99,325.26 5,952.10 -1.1%
Zydus Lifesciences Ltd. 96,553.18 959.45 0.0%
Mankind Pharma Ltd. 95,896.87 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. 89,224.37 2,637.40 +1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 39.97 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-12 29.34 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 72.36 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.00 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.47 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 55.52 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 59.72 2,637.40 +1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.71 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-12 4.20 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-12 7.68 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.70 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.12 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 10.79 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.48 2,637.40 +1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,637.40 +1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,637.40 +1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,637.40 +1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,637.40 +1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,346.70 -0.6%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,768.65 +0.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,952.10 -1.1%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,393.05 +2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,637.40 +1.8%

Ortin Laboratories Ltd. FAQ's

What is Ortin Laboratories share price?

Can I buy Ortin Laboratories shares now?

What is the Market Cap of Ortin Laboratories?

What are the key metrics to analyse Ortin Laboratories?

What is the 52 Week High and Low of Ortin Laboratories?

What is the trend of Ortin Laboratories share price?